Alzheimer's disease is linked to hidden abdominal fat in middle age

Alzheimer's disease is linked to hidden abdominal fat in middle age
Illinois, USA
ANI
According to a study that will be presented next week at the annual conference of the Radiological Society of North America (RSNA), the development of Alzheimer's disease is connected with higher levels of visceral abdominal fat in midlife.
Visceral fat is fat that surrounds internal organs deep within the abdomen.
Researchers have linked this hidden belly fat to brain changes that can occur up to 15 years before the first signs of Alzheimer's disease, such as memory loss.
According to the Alzheimer's Association, about 6 million Americans have Alzheimer's disease. By 2050, this figure is predicted to rise to over 13 million. Alzheimer's disease affects one out of every five women and one out of every ten men at some time in their lives.
Researchers investigated the relationship between brain MRI volumes, as well as amyloid and tau uptake on positron emission tomography (PET) scans, and body mass index (BMI), obesity, insulin resistance, and abdominal adipose (fatty) tissue in a cognitively normal midlife population. Amyloid and tau proteins are thought to disrupt communication between brain cells.
"Even though there have been other studies linking BMI with brain atrophy or even a higher dementia risk, no prior study has linked a specific type of fat to the actual Alzheimer's disease protein in cognitively normal people," said study author Mahsa Dolatshahi, MD, MPH, a post-doctoral research fellow with Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine in St. Louis.
"Similar studies have not investigated the differential role of visceral and subcutaneous fat, especially in terms of Alzheimer's amyloid pathology, as early as midlife."
For this cross-sectional study, researchers analyzed data from 54 cognitively healthy participants, ranging in age from 40 to 60 years old, with an average BMI of 32. The participants underwent glucose and insulin measurements, as well as glucose tolerance tests.
The volume of subcutaneous fat (fat under the skin) and visceral fat were measured using abdominal MRI. Brain MRI measured the cortical thickness of brain regions that are affected by Alzheimer's disease.
PET was used to examine disease pathology in a subset of 32 participants, focusing on amyloid plaques and tau tangles that accumulate in Alzheimer's disease.
The researchers found that a higher visceral to subcutaneous fat ratio was associated with higher amyloid PET tracer uptake in the precuneus cortex, the region known to be affected early by amyloid pathology in Alzheimer's disease. This relationship was worse in men than in women. The researchers also found that higher visceral fat measurements are related to an increased burden of inflammation in the brain.
"Several pathways are suggested to play a role," Dolatshahi said. "Inflammatory secretions of visceral fat--as opposed to potentially protective effects of subcutaneous fat--may lead to inflammation in the brain, one of the main mechanisms contributing to Alzheimer's disease."
Senior author Cyrus A Raji, MD, PhD, associate professor of radiology and neurology, and director of neuromagnetic resonance imaging at MIR, noted that the findings have several key implications for earlier diagnosis and intervention.
"This study highlights a key mechanism by which hidden fat can increase the risk of Alzheimer's disease," he said. "It shows that such brain changes occur as early as age 50, on average--up to 15 years before the earliest memory loss symptoms of Alzheimer's occur."
Raji added that the results may point to visceral fat as a treatment target to modify the risk of future brain inflammation and dementia.
"By moving beyond body mass index in better characterizing the anatomical distribution of body fat on MRI, we now have a uniquely better understanding of why this factor may increase the risk for Alzheimer's disease," he said.